After surgery for colorectal cancer and a fixed number of preventive (adjuvant) chemotherapy cycles, many people find a CT appointment waiting just a few days after the final infusion. If no spread to other organs was found at surgery, it is natural to wonder what a scan could possibly show when there is nothing to compare it against. In practice, however, a scan taken at this point is often used for a different purpose than measuring whether a tumor has shrunk or grown.

The first fork is the baseline scan. Recording the state of the body at the moment treatment ends gives clinicians a reference point for everything that follows. Common incidental findings such as liver cysts, very small lung nodules, or post-surgical changes around the operated area are often difficult to judge from a single image, and having a prior study to compare against makes later interpretation far easier.

The second fork is whether something specific needs checking now. Adjuvant chemotherapy targets microscopic cells that imaging cannot see, so confirming its effect visually is usually not the point. But if an area was left undecided on pre-operative imaging, or if tumor marker values or symptoms shifted during treatment, a scan now carries real meaning. Which of these applies is something the treating team can usually answer in a single sentence.

The third fork is where this scan sits in the surveillance schedule. Follow-up after colorectal cancer surgery generally combines clinic visits, blood tests including tumor markers, imaging, and colonoscopy at set intervals over several years, with the intervals widening as time passes. The exact spacing varies by guideline, stage, estimated recurrence risk, and how a given center organizes care. Rather than settling on a general rule about how many months should pass, it is usually more useful to ask where this particular scan falls within the multi-year plan.

The fourth fork is the burden of the test itself. If vomiting continued for days after a previous CT, the preparation differs depending on whether it was a reaction to the contrast media, an overlap of fasting with the immediate post-chemotherapy state, or related to medications given around the scan. Any past reaction should be reported during the pre-scan interview, and where appropriate, premedication, an adjusted imaging protocol, a check of kidney function, and a hydration plan can be discussed in advance. Postponing out of fear and going ahead with proper preparation are two different options.

Before asking to move the date, it helps to write down six things: the purpose of this particular CT; when symptoms began after the last scan, how long they lasted, and what medication was used; the date of recent blood work along with kidney function and tumor marker results; what is gained and what is deferred by scanning now versus in a few months; when the next imaging study and colonoscopy are expected; and which symptoms after a scan warrant an immediate call. With these in hand, the conversation shifts from whether to scan at all to when and with what preparation.

This article is general information and does not replace individual medical care. The timing and method of imaging depend on stage, surgical and treatment history, and current condition, so please discuss any decision with your own medical team.